Concord Drugs Ltd

BSE :538965 NSE :- Sector : Pharmac..
34.32
Change: 2.33(7.28%)
52 week Low
28.50
52 week High
44.42
Day low
31.96
Day high
34.79
Prev Close
31.99
Open
32.63
6M return
5.41%
1Y return
-13.86%
MCap(Rs. in Cr.)
31.99
Total Volume
3,249
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Concord Drugs
34.32
Change: 2.33 (7.28%)
1 Year return
-13.86%
Risk (Std Dev)
0.06%
PE Ratio
NM
MCap( in Cr.)
31.99
Fermenta Biotec.
269.35
Change: -9.50 (-3.41%)
1 Year return
33.71%
Risk (Std Dev)
0.17%
PE Ratio
23.10273
MCap( in Cr.)
820.68
Bharat Parenter.
989.55
Change: 47.10 (5.00%)
1 Year return
-11.57%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
649.53
Jenburkt Pharma
1,020.00
Change: 53.30 (5.51%)
1 Year return
28.63%
Risk (Std Dev)
0.13%
PE Ratio
13.58
MCap( in Cr.)
426.63
Kerala Ayurveda
315.45
Change: 1.95 (0.62%)
1 Year return
13.51%
Risk (Std Dev)
0.16%
PE Ratio
505.64516
MCap( in Cr.)
377.22
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Concord Drugs reports consolidated net profit of Rs 0.23 crore in the December 2024 quarter

Net profit of Concord Drugs reported to Rs 0.23 crore in the quarter ended December 2024 as against net loss of Rs 0.24 crore during the previous quar....

13 Jan 2025 07:32

Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 11 January 2025.Powered by Capital Market - Live News</....

08 Jan 2025 10:15

Concord Drugs consolidated net profit declines 92.86% in the September 2024 quarter

Net profit of Concord Drugs declined 92.86% to Rs 0.04 crore in the quarter ended September 2024 as against Rs 0.56 crore during the previous quarter ....

14 Nov 2024 10:24

Concord Drugs announces board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 13 November 2024.Powered by Capital Market - Live News<....

08 Nov 2024 12:33

Concord Drugs to conduct AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market ....

19 Sep 2024 17:57

Concord Drugs consolidated net profit declines 93.88% in the June 2024 quarter

Net profit of Concord Drugs declined 93.88% to Rs 0.03 crore in the quarter ended June 2024 as against Rs 0.49 crore during the previous quarter ended....

10 Aug 2024 07:33

View More
Subscribe for our
newsletter
Open Account Now